Skip to main content

Table 3 Participant demographics displayed per lustrum of age. Data presented as Mean(SD), Median(IR), or geometric mean

From: The difference in sleep, sedentary behaviour, and physical activity between older adults with ‘healthy’ and ‘unhealthy’ cardiometabolic profiles: a cross-sectional compositional data analysis approach

VariableAge Group (years)
Pooled60–6566–7172–7778–8384+
n93101931249
Female (%)559047545433
Covariates
 Directly CVD Meds (n∙day− 1)a1.17 (1.52)0.30 (0.48)0.74 (1.37)1.39 (1.61)1.39 (1.53)1.78 (1.92)
 (In)directly CVD Meds (n∙day−1)b1.62 (1.81)0.70 (0.67)1.05 (1.51)1.81 (1.97)2.04 (1.92)2.11 (1.96)
 Inn+ (In)directly CVD Meds (mg∙day−1)c157.86 (486.49)293.40 (797.89)54.71 (73.39)93.19 (293.99)136.67 (323.71)494.88 (1085.38)
 BP Meds (mg∙day−1)9.81 (50.79)3.50 (6.73)5.47 (13.29)2.35 (4.89)8.05 (16.71)53.00 (154.35)
 Lipid-Lowering Meds (mg∙day−1)8.12 (16.58)11.00 (16.63)9.41 (15.60)3.57 (10.96)13.33 (23.09)4.44 (13.33)
Cardio-metabolic Parameters
 Triglyceride (mmol∙l−1)1.77 (0.81)m2.09 (0.86)m1.51 (0.84)m1.73 (0.68)m1.88 (0.56)m1.89 (0.57)m
 Total Cholesterol (mmol∙l−1)5.44 (1.39)m6.06 (0.95)5.64 (1.08)5.45 (1.07)5.64 (0.89)5.27 (0.66)
 Glucose (mmol∙l−1)5.72 (1.10)m5.81 (0.81)m5.85 (1.35)m5.60 (1.33)m5.65 (1.38)m6.00 (1.11)m
 HbA1c (%)5.29 (0.31)5.18 (0.22)5.30 (0.22)5.34 (0.36)5.24 (0.33)5.38 (0.32)
 LPL (pg∙mL−1)113.02 (147.80)m174.35 (277.28)m119.13 (127.16)m83.41 (123.97)m117.88 (147.07)m247.58 (332.56)m
 IL-6 (pg∙mL−1)2.72 (2.77)m3.11 (1.85)m2.39 (2.85)m2.55 (3.29)m2.36 (2.98)m4.14 (6.00)m
 PIIINP (pg∙mL−1)229.21 (247.97)m205.05 (239.21)m229.21 (208.30)m316.92 (228.81)m167.19 (248.76)m256.99 (406.27)m
sleep, sedentary behaviour, and physical activity parameters
 Sleep (hrs∙day−1)8.43 (0.77) 8.40g7.88 (0.83) 7.84g8.49 (0.53) 8.48g8.41 (0.73) 8.35g8.62 (0.79) 8.58g8.50 (1.04) 8.45g
 SB (hrs∙day−1)9.65 (1.33) 9.56g9.81 (1.31) 9.73g9.34 (1.38) 9.25g9.61 (1.36) 9.53g9.59 (1.29) 9.51g10.49 (1.15) 10.44g
 Standing (hrs∙day−1)1.09 (0.41) 1.02g1.19 (0.30) 1.14g1.16 (0.43) 1.08g1.11 (0.39) 1.03g1.08 (0.43) 1.00g0.89 (0.43) 0.81g
 LIPA (hrs∙day−1)1.97 (0.63) 1.86g2.11 (0.49)
2.05g
1.86 (0.59) 1.78g2.06 (0.63) 1.95g1.99 (0.68) 1.88g1.73 (0.77) 1.57g
 sMVPA (hrs∙day−1)2.57 (0.64) 2.49g2.68 (0.58) 2.62g2.86 (0.56) 2.80g2.55 (0.59) 2.49g2.53 (0.69) 2.42g2.07 (0.67) 1.96g
10MVPA (hrs∙day−1)0.08 (0.20)m 0.06g0.06 (0.16)m 0.07g0.15 (0.29)m 0.13g0.08 (0.21)m 0.05g0.09 (0.22)m 0.07g0.07 (0.13)m 0.03g
10MVPAd (hrs∙day−1)0.48 (0.36) 0.40g0.53 (0.30) 0.43g0.47 (0.22) 0.43g0.54 (0.51) 0.43g0.39 (0.17) 0.35g0.28 (0.09) 0.27g
  1. a Participants are currently prescribed an amount of medication that reduces the risk or treats CVD (i.e. statins, warfarin). b Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a side effect. c Participants are currently prescribed a medication that may affect the cardiovascular system either directly or as a side effect, including inflammatory medication. d Excluding 49 participants who accumulated < 10 min of 10MVPA in a week (variable not used in CoDA). m Median (IR). g Geometric mean